多血小板血漿市場規模、シェア、成長分析、タイプ別、由来別、用途別、エンドユーザー別、地域別 - 業界予測、2024～2031年

多血小板血漿の世界市場規模は、2022年に4億7,853万米ドルと評価され、2023年の5億3,978万米ドルから2031年には14億1,479万米ドルに成長し、予測期間中（2024～2031年）のCAGRは12.8%で成長する見通しです。

多血小板血漿（PRP）注射市場は、様々な症状、特に脱毛やスポーツ外傷に対する効果的な治療法として人気が急上昇しています。この革新的な処置は、患者自身の血液細胞を利用して、標的部位の治癒と回復を促進します。PRP注射は、テニス肘やジャンパー膝のような慢性的な症状に対して、回復時間を大幅に早め、痛みを軽減し、活動への素早い復帰を促し、筋骨格系の傷害への対処に有効であることが実証されています。外科手術や再生医療におけるPRPの採用の高まりは、広範な医学研究の道を開き、市場の成長をさらに促進しています。この動向は、スポーツ傷害の発生率の増加や、歯科および歯周外科におけるPRP応用の拡大によって後押しされています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2023年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制情勢
• 特許分析
• ケーススタディ

多血小板血漿市場規模：タイプ別およびCAGR（2024～2031年）

• 市場概要
• 純多血小板血漿（P-PRP）
• 白血球含有多血小板血漿（L-PRP）
• 白血球含有線維素（L-PRF）
• その他

多血小板血漿市場規模：由来別およびCAGR（2024～2031年）

• 市場概要
• 自家多血小板血漿
• 他家多血小板血漿
• 同種多血小板血漿

多血小板血漿市場規模：用途別およびCAGR（2024～2031年）

• 市場概要
• 整形外科および脊椎外科
• 美容整形と美容
• 一般外科
• 脳神経外科
• その他

多血小板血漿市場規模：エンドユーザー別およびCAGR（2024～2031年）

• 市場概要
• 病院と診療所
• 調査機関
• その他

多血小板血漿市場規模およびCAGR（2024～2031年）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2023年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2023年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2021～2023年）

主要企業プロファイル

• Harvest Technology（USA）
• Stryker Corporation（USA）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）
• APEX Biologix（USA）
• Juventix Regenerative Medical, LLC（Italy）
• Dr. PRP USA LLC（USA）
• Ycellbio Medical Co., Ltd.（South Korea）
• EmCyte Corporation（USA）
• Regen Lab SA（Switzerland）
• Zimmer Biomet（USA）
• Arthrex Inc.（USA）
• Terumo BCT Inc.（USA）
• Celling BioSciences Inc.（USA）

結論と推奨事項

Global Platelet Rich Plasma Market size was valued at USD 478.53 million in 2022 and is poised to grow from USD 539.78 million in 2023 to USD 1414.79 million by 2031, growing at a CAGR of 12.8% during the forecast period (2024-2031).

The market for platelet-rich plasma (PRP) injections is experiencing a surge in popularity as effective treatments for various conditions, particularly hair loss and sports injuries. This innovative procedure utilizes the patient's own blood cells to enhance healing and recovery in targeted areas. PRP injections have demonstrated efficacy in addressing musculoskeletal injuries, significantly accelerating recovery times, reducing pain, and facilitating quicker returns to activity for chronic conditions like tennis elbow and jumper's knee. The rising adoption of PRP in surgical and regenerative medicine has opened avenues for extensive medical research, further fueling market growth. This trend is bolstered by an increasing incidence of sports injuries, as well as the expansion of PRP applications in dental and periodontal surgeries.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Platelet Rich Plasma market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Platelet Rich Plasma Market Segmental Analysis

Global Platelet Rich Plasma Market is segmented by type, origin, application, by end-user and region. Based on type, the market is segmented into pure platelet rich plasma (P-PRP), leukocyte-rich platelet rich plasma (L-PRP), leukocyte-rich fibrin (L-PRF) and others. Based on origin, the market is segmented into autologous PRP, allogeneic PRP and homologous PRP. Based on application, the market is segmented into orthopedic and spinal surgery, cosmetic surgery and aesthetics, general surgery, neurosurgery and others. Based on end-user, the market is segmented into hospitals and clinics, research institutes and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Platelet Rich Plasma Market

The Platelet Rich Plasma (PRP) market is driven by a significant increase in demand for PRP treatments in orthopaedic disorders, musculoskeletal issues, and sports injuries. This surge can be attributed to PRP's ability to harness growth factors that enhance healing processes. As a personalized regenerative medicine approach, PRP is vital in promoting wound healing and restoring tissue, leading to its extensive application in managing conditions like osteonecrosis and post-tooth extraction healing. Additionally, the versatile use of PRP in aesthetic procedures such as skin rejuvenation, acne scar treatment, and alopecia further fuels market growth, owing to its effectiveness in stimulating collagen production and extracellular matrix reconstruction. As various therapeutic advancements are anticipated, the PRP market is poised for robust expansion in the coming years.

Restraints in the Global Platelet Rich Plasma Market

The anticipated growth of the global platelet rich plasma market during the forecast period is likely to face significant challenges due to the increasing fluctuations in the pricing of platelet-rich plasma therapy. Additionally, the market's expansion could be further restricted by concerns related to quality control and the reliability of test results. Furthermore, the necessity for official FDA approval for specific end-use applications adds another layer of complexity, which may hinder overall market development. These factors combine to create a challenging environment that could stifle the potential growth of the platelet rich plasma market in the coming years.

Market Trends of the Global Platelet Rich Plasma Market

The Global Platelet Rich Plasma (PRP) market is witnessing significant growth, largely fueled by its effectiveness in enhancing hair density and promoting hair follicle development. As PRP is derived from the patient's own blood, it presents a compelling advantage due to its safety profile, minimizing risks of infectious diseases. This innovative treatment is increasingly sought after as both a standalone procedure and in conjunction with hair transplants. Despite the mild side effects commonly associated with PRP, ongoing research aims to solidify its efficacy and establish standardized protocols, ensuring optimal patient outcomes while expanding the market's reach across therapeutic applications.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Landscape
• Patent Analysis
• Case Studies

Global Platelet Rich Plasma Market Size by Type & CAGR (2024-2031)

• Market Overview
• Pure Platelet Rich Plasma (P-PRP)
• Leukocyte-Rich Platelet Rich Plasma (L-PRP)
• Leukocyte-Rich Fibrin (L-PRF)
• Others

Global Platelet Rich Plasma Market Size by Origin & CAGR (2024-2031)

• Market Overview
• Autologous PRP
• Allogeneic PRP
• Homologous PRP

Global Platelet Rich Plasma Market Size by Application & CAGR (2024-2031)

• Market Overview
• Orthopedic and Spinal Surgery
• Cosmetic Surgery and Aesthetics
• General Surgery
• Neurosurgery
• Others

Global Platelet Rich Plasma Market Size by End-User & CAGR (2024-2031)

• Market Overview
• Hospitals and Clinics
• Research Institutes
• Others

Global Platelet Rich Plasma Market Size & CAGR (2024-2031)

• North America (Type, Origin, Application, End-User)
  • USA
  • Canada
• Europe (Type, Origin, Application, End-User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Origin, Application, End-User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Origin, Application, End-User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Origin, Application, End-User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• Harvest Technology (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Stryker Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• APEX Biologix (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Juventix Regenerative Medical, LLC (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dr. PRP USA LLC (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ycellbio Medical Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EmCyte Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Regen Lab SA (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Arthrex Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo BCT Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celling BioSciences Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations